We provide fractional CXO expertise for FemTech companies navigating regulatory complexity, trust-building challenges, and sustainable scaling in a market where ad platform rules and state privacy laws keep shifting.
The Problem
Traditional executives don't understand FemTech-specific regulatory and cultural dynamics
Generic C-level hires bring SaaS or healthcare backgrounds but not the specifics of women's health: platform ad restrictions on reproductive health content, cultural taboos around intimate topics, and the trust-building work required before a user shares cycle or fertility data. Your team runs standard growth playbooks that get flagged or throttled while FemTech-savvy competitors pull ahead.
Fundraising timelines don't line up with executive hiring
Investors want senior leadership in place before they wire funds, but you cannot justify a C-level salary until after the round closes. A full-time executive search runs 3-6 months – time you do not have when an ad platform policy shift or state privacy law needs a response now, not next quarter.
Women's health expertise doesn't scale across every business function
Your founders understand the clinical and user-experience side of women's health but not how to scale operations, build compliant marketing systems, or manage a rollout across different state privacy regimes. Promote from within and you get skill gaps; hire externally and the new exec needs months to learn the market.
Boards expect SaaS metrics that don't fit FemTech adoption curves
Women's health products earn trust slower than typical B2B SaaS, and board growth targets often ignore that. You need an executive who can translate FemTech-appropriate metrics – retention through trust milestones, not just signups – into numbers your board will act on. Without that translation, every board meeting turns into a fight over the wrong numbers.
How We Help
Our fractional CXO service gives you senior FemTech leadership without the $300K-plus full-time salary. We have scaled women's health companies through ad platform restrictions, state-by-state privacy law changes, and the slower trust curve that defines this category – problems a generic fractional CXO has not had to solve firsthand. We show up in your board meetings and your Monday leadership standups, not just quarterly reviews.
The first 30 days is a FemTech market assessment: we audit your business model against category-specific risk – ad platform compliance, state health-data privacy exposure, and metrics that do not match investor expectations – then rebuild your strategic planning around what actually works in this category. That plan becomes what your team and board operate from, not a deck that gets shelved after the kickoff.
Next we build the operational systems FemTech companies actually need: ad creative and targeting that survives platform review, marketing funnels compliant with the privacy laws in your target states, and a go-to-market motion built around the trust-building step every women's health product has to earn before conversion. We work across marketing, product, and finance to put these in place, not just recommend them on a slide.
We embed into daily operations – board meetings, investor updates, cross-functional leadership syncs – as a working member of your team, not an outside advisor billing hours for opinions. That includes hands-on work on fundraising materials, partnership terms, and regulatory sign-off, plus the fractional CXO judgment calls your team needs before a board meeting, not after.
The engagement ends with a handoff, not a dependency: documented FemTech playbooks, metrics your board already understands, and a leadership team that has watched the decisions get made in real time. That is the foundation you need before hiring, or promoting into, a full-time executive who understands this market.
What we deliver
- Immediate senior leadership with FemTech regulatory and scaling expertise – no 3-6 month search
- Business model review against current ad platform and state privacy law constraints
- Compliant marketing and customer acquisition systems built for the FemTech trust curve
- Board and investor communication using FemTech-appropriate metrics, not generic SaaS benchmarks
- Leadership team development so your company is ready for a full-time hire when the time comes
FemTech companies fail when they run traditional SaaS playbooks against a market with a slower trust curve and shifting ad-platform and privacy rules. The leadership gap isn't business acumen – it's not knowing which rules apply this quarter.
Our Methodology
Month one is assessment: business review, regulatory and ad-platform risk audit, and board alignment on FemTech-appropriate metrics. Month two is implementation – operational fixes and go-to-market changes specific to women's health constraints. Month three builds the processes that let this run without us in the room permanently, or sets up a longer engagement if the company is still scaling fast. Unlike a traditional consulting retainer, we are an active leadership team member from day one – in the meetings, accountable for the calls we make, not just the memos we write.
How We Work
Week one is an intensive assessment: current strategy, ad-platform and state privacy compliance status, and growth metrics against women's health benchmarks, plus stakeholder interviews with your team, board, and key investors to find where expectations and market reality have drifted apart.
Days 7-60 is implementation. We sit in weekly leadership meetings, board calls, and planning sessions as an integrated team member, working directly with marketing, product, and operations to put FemTech-specific practices in place. We support fundraising conversations, partnership terms, and compliance decisions as they come up. Expect 15-20 hours a week of direct engagement during this phase.
Days 60-90 shifts to sustainability: FemTech-appropriate reporting your board can actually use, mentorship for your internal leaders, and documented frameworks so the strategy survives past our engagement. Most clients extend quarterly as they scale, with an option to step down to an advisory role once a full-time executive is in place.
- Business model and metrics rebuilt around FemTech-specific growth patterns
- Senior leadership impact without a full-time executive salary
If your femtech company needs fractional cxo leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
How much does a fractional CXO engagement cost for FemTech companies?
Most FemTech fractional CXO engagements run $15,000 to $35,000 a month depending on scope and complexity – roughly 40-60% less than a full-time senior executive's total comp. That covers strategic planning, board participation, and operational work. Clients typically see strategic clarity within 30 days and operational changes within 60-90 days.
How long before we see results from fractional CXO leadership?
Board alignment and strategic clarity show up in the first 2-3 weeks. Operational changes – compliant marketing systems, revised metrics – land around day 30-45. Real growth impact from FemTech-specific strategy typically shows at 60-90 days. Full transformation runs 4-6 months because trust-building in women's health moves slower than standard B2B sales.
How does a fractional CXO integrate with our existing leadership team?
We join your leadership team directly: every strategic meeting, board call, and major decision, plus weekly one-on-ones with key team members and monthly planning sessions. Expect 15-20 hours a week during active phases, with mentorship built into day-to-day work rather than delivered as a separate training track.
What makes Winston Francois different from a traditional fractional CXO service?
Most fractional executives bring general business strategy without FemTech-specific context: ad platform restrictions, state privacy law, and the slower trust curve that defines women's health adoption. We have worked through those constraints directly, so our strategy accounts for them instead of hitting them for the first time on your dime.
How do you measure ROI from a fractional CXO engagement?
We track FemTech-appropriate metrics – compliance status, trust-milestone retention, and sustainable growth rate – alongside standard revenue numbers, because revenue alone misreads a slower-trust category. ROI shows up as near-term strategic fixes and longer-term gains in scaling capability and board confidence in your numbers.
What type of FemTech company is the right fit for this service?
We work best with Series A through growth-stage FemTech companies with product-market fit but facing scaling friction: ad platform compliance issues, privacy law exposure, or a board that does not buy the growth story yet. Companies heading into a raise get the most value. The first step is a strategic assessment.
